SCHEMBL21980601

SCHEMBL21980601

Cc1nc2cc3nc([SH]4C=CC=C4)cnc3cc2n1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.50
KIT P10721 1/20 0.50
FLT3 P36888 1/20 0.50
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 3/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 5/20 0.38
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.33
GLA P06280 1/20 0.33
HPGD P15428 1/20 0.33
NPC1 O15118 5/20 0.32
RAB9A P51151 5/20 0.32
POLB P06746 1/20 0.32
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HDAC1 Q13547 1/20 0.30
NAMPT P43490 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6202965 0.74 KDM4E (0.56) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL13916682 0.74 KDM4E (0.69) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL13916685 0.72 KDM4E (0.67) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL843785 0.70 PDGFRB (0.65) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL6200577 0.70 PDGFRB (0.65) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL844287 0.67 PDGFRB (1.00) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL844223 0.67 PDGFRB (1.00) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL27306910 0.65 ALDH1A1 (0.53) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL862261 0.65 KDM4E (0.62) PDGFRBKITFLT3KDM4EALDH1A1
SCHEMBL14871089 0.64 KDM4E (0.52) PDGFRBKITFLT3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11712419-B2 Liposome formulations OPKO PHARMACEUTICALS, LLC (US) 2023-08-01 US disclosed
US-20200163877-A1 LIPOSOME FORMULATIONS OPKO PHARMACEUTICALS, LLC. 2020-05-28 US disclosed